119 related articles for article (PubMed ID: 38725310)
1. Efficacy of neoadjuvant chemotherapy combined with surgery in patients with nonsmall cell lung cancer: A meta-analysis.
Dong HJ; Yang CY
Clin Respir J; 2024 May; 18(5):e13756. PubMed ID: 38725310
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials.
Zhang Y; Hu X; Liu D; Wang R; Sun X; Peng Z; Ren H; Du N
Surg Oncol; 2021 Sep; 38():101590. PubMed ID: 34091269
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
[TBL] [Abstract][Full Text] [Related]
4. The Value of Perioperative Immunotherapy for Non-Small Cell Lung Cancer: A Pool- and Meta-Analysis.
Wu Y; Hu L; Zhang S; Zhang H
Technol Cancer Res Treat; 2024; 23():15330338241258164. PubMed ID: 38872482
[No Abstract] [Full Text] [Related]
5. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
Xu YP; Li B; Xu XL; Mao WM
Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.
Song WA; Zhou NK; Wang W; Chu XY; Liang CY; Tian XD; Guo JT; Liu X; Liu Y; Dai WM
J Thorac Oncol; 2010 Apr; 5(4):510-6. PubMed ID: 20107424
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer.
Zhang T; Guo Q; Zhang Y; Liu Z; Zhou S; Xu S
J Cancer Res Ther; 2018 Jan; 14(1):139-144. PubMed ID: 29516976
[TBL] [Abstract][Full Text] [Related]
9. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
[TBL] [Abstract][Full Text] [Related]
10. Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis.
Ma J; Li X; Zhao S; Wang J; Zhang W; Sun G
BMC Cancer; 2021 May; 21(1):498. PubMed ID: 33941112
[TBL] [Abstract][Full Text] [Related]
11. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the efficacy of postoperative adjuvant chemotherapy for stage IB non-small cell lung cancer.
Liu S; Wan S; Feng J; Pang Y; Wang H; Zeng H; Xu X
Medicine (Baltimore); 2024 Jan; 103(1):e36839. PubMed ID: 38181235
[TBL] [Abstract][Full Text] [Related]
13. Cinobufotalin injection combined with chemotherapy for the treatment of advanced NSCLC in China: A PRISMA-compliant meta-analysis of 29 randomized controlled trials.
Zhang F; Yin Y; Xu T
Medicine (Baltimore); 2019 Aug; 98(35):e16969. PubMed ID: 31464940
[TBL] [Abstract][Full Text] [Related]
14. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.
Huang X; Pang G; Mao Z; Li B; Teng Z; Yang Y; Qiu Z; Chen X; Wang P
Clin Respir J; 2024 May; 18(5):e13761. PubMed ID: 38693705
[TBL] [Abstract][Full Text] [Related]
16. Video-assisted thoracoscopic surgery lobectomy versus open lobectomy in patients with clinical stage Ⅰ non-small cell lung cancer: a meta-analysis.
Chen FF; Zhang D; Wang YL; Xiong B
Eur J Surg Oncol; 2013 Sep; 39(9):957-63. PubMed ID: 23845704
[TBL] [Abstract][Full Text] [Related]
17. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
[TBL] [Abstract][Full Text] [Related]
20. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
